TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18756957

Group type: EXPERIMENTAL
Intervention: Fibroid pedicle ligation (Group A)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Injected with 12 IU diluted vasopressin around the myoma (Group B)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Injected with 20 IU oxytocin combined with pedicle ligation (Group C)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Injected with vasopressin combined with pedicle ligation (Group D)
Number of subjects: 280
Study: 17054789

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study: 15831780

Group type: EXPERIMENTAL
Intervention: Cefpodoxime (400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefixime (400 mg)
Number of subjects: 0
Study: 11572104

Group type: EXPERIMENTAL
Intervention: New cognitive-emotional cognitive-behavioral therapy programmes (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional social skills training programme (control group, IPT 'Social Skills' subprogramme)
Number of subjects: 0
Study: 9815827

Group type: EXPERIMENTAL
Intervention: MRP expression (low, intermediate, high)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: P-glycoprotein-positive AML
Number of subjects: 80
Study: 7703703

Group type: EXPERIMENTAL
Intervention: Alcohol and Behavioral Marital Therapy (ABMT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: ABMT plus Alcoholics Anonymous and Alanon (AA/ABMT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: ABMT plus Relapse Prevention (RP/ABMT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Early treatment dropouts
Number of subjects: 105

Group type: COMPARATOR
Intervention: Partial completers
Number of subjects: 105
Study: 3477353

Group type: EXPERIMENTAL
Intervention: Special caries preventive program with controlled antimicrobial treatment using Streptococcus mutans as an indicator organism.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 101
Study: 31898212

Group type: EXPERIMENTAL
Intervention: Atypical anti-psychotics
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Typical anti-psychotics
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Selective-serotonin reuptake inhibitors (SSRIs)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Tricyclic anti-depressants (TCAs)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Atypical anti-depressants
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Combination anti-depressants
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: SNRIs
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: TCAs
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Anti-convulsants
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Combination of antipsychotics and anti-depressants
Number of subjects: 992
Study: 30516172

Group type: COMPARATOR
Intervention: Environmental noise with alarm sounds (C3)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Environmental noise without alarm sounds (C2)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard condition (C1)
Number of subjects: 15
Study: 27655384

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) targeting the right temporoparietal area for 20 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cathodal transcranial direct current stimulation (tDCS) targeting the right temporoparietal area
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation targeting the right temporoparietal area
Number of subjects: 0
Study: 26578205

Group type: EXPERIMENTAL
Intervention: ENVIE program (add-on intervention)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 332
Study: 24244687

Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 0
Study: 21164120

Group type: EXPERIMENTAL
Intervention: Standardized measurement methods and training of therapist assessors
Number of subjects: 15
Study: 19061746

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (8 weekly sessions in the first 2 months, followed by biweekly sessions for 4 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention
Number of subjects: 0
Study: 16547994

Group type: EXPERIMENTAL
Intervention: Oral fluid intake
Number of subjects: 524

Group type: COMPARATOR
Intervention: Before hydration
Number of subjects: 524
Study: 12665978

Group type: EXPERIMENTAL
Intervention: Sub-maximal inertial contractions at 20%, 30%, 40%, 50%, 60%, 70%, 80%, and 90% of their 1-RM
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sub-maximal inertial contractions at various intensities
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of absolute and relative mass lifted
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Perceived exertion response to relative load
Number of subjects: 30
Study: 10355012

Group type: EXPERIMENTAL
Intervention: 5% EMLA cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% dyclonine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% benzocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10% cocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10% lidocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 0
Study: 7503000

Group type: EXPERIMENTAL
Intervention: Integrelin (dosing regimens: 180 and 135 micrograms/kg bolus, followed by 0.75 micrograms/kg/min infusion)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Integrelin (0.50 micrograms/kg/min infusion)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Integrelin with aspirin and heparin
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Integrelin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 2023749

Group type: EXPERIMENTAL
Intervention: Timolol treatment
Number of subjects: 143

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 143
Study: 7016244

Group type: EXPERIMENTAL
Intervention: Stripping of the long saphenous vein
Number of subjects: 2

Group type: COMPARATOR
Intervention: No stripping of the long saphenous vein
Number of subjects: 2
Study: 29125017

Group type: EXPERIMENTAL
Intervention: 3 sets of resistance training (G3S, n = 20)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 1 set of resistance training (G1S, n = 21)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CG, n = 21)
Number of subjects: 62
Study: 28288570

Group type: EXPERIMENTAL
Intervention: Tolvaptan 15, 30 and 45 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tolvaptan with NO-inhibition
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 25796417

Group type: EXPERIMENTAL
Intervention: Colonic stents in the curative setting
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Colonic stents for palliation
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Surgery for curable disease
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Colonic stents vs surgery
Number of subjects: 96
Study: 23780373

Group type: EXPERIMENTAL
Intervention: Midday moderate-intensity exercise (45 minutes)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 10
Study: 21086279

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/benzydamine plus paracetamol
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo plus paracetamol
Number of subjects: 164
Study: 18436178

Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 0
Study: 16796925

Group type: EXPERIMENTAL
Intervention: Immunonutrition (Supportan and glutamine, calorific value of 125.4 kJ.kg(‐1).d(‐1), given orally or by nasointestinal tube for 5 days before operation, and through nasointestinal tube post-operatively from day 2 to day 9)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (Nutrition with the same calorific value given in the same manner)
Number of subjects: 80
Study: 14604457

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy in patients who developed depression within the first 4 weeks
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy in patients who developed depression later
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy in patients with no psychiatric symptoms
Number of subjects: 146
Study: 10794114

Group type: EXPERIMENTAL
Intervention: Classical acupuncture
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 132
Study: 9038464

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia using morphine 1 mg bolus with a 10-min lockout and no background infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intramuscular codeine phosphate
Number of subjects: 30
Study: 1886957

Group type: EXPERIMENTAL
Intervention: Weak visual stimuli presented at 0, 150, 250, 350, or 500 ms after the R-wave of the electrocardiogram with an intensity yielding either 63% or 90% correct detections
Number of subjects: 24

Group type: COMPARATOR
Intervention: Instructions to judge which of two weak visual stimuli occurred
Number of subjects: 24

Group type: COMPARATOR
Intervention: Instructions to execute a speeded, discriminative response to the stimuli
Number of subjects: 24
Study: 6138089

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3993546

Group type: COMPARATOR
Intervention: Propranolol, 160 mg/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Atenolol, 100 mg/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 31983653

Group type: EXPERIMENTAL
Intervention: CNIC polypill (atorvastatin 40mg/ramipril 10mg/aspirin 100mg)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Atorvastatin (40mg)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Ramipril (10mg)
Number of subjects: 241
Study: 29478933

Group type: EXPERIMENTAL
Intervention: 0.014" A‐NiTi (n=30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 0.016" Heat Activated NiTi (HANT) (n=29)
Number of subjects: 59
Study: 28033332

Group type: EXPERIMENTAL
Intervention: Direct Renin Inhibitor (DRI) - Aliskiren
Number of subjects: 225

Group type: COMPARATOR
Intervention: Angiotensin Receptor Blockers (ARBs)
Number of subjects: 225
Study: 25006068

Group type: EXPERIMENTAL
Intervention: Zilpaterol hydrochloride (ZH; 8.3 mg/kg [100% DM basis]) for 20 d
Number of subjects: 2275

Group type: EXPERIMENTAL
Intervention: Ractopamine hydrochloride (RH; 30.1 mg/kg [100% DM basis]) for 28 d
Number of subjects: 2275

Group type: COMPARATOR
Intervention: Control diet containing no β‐agonists
Number of subjects: 2275
Study: 22865016

Group type: EXPERIMENTAL
Intervention: Combined behavioral management and medication management intervention
Number of subjects: 573

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 573
Study: 20230350

Group type: EXPERIMENTAL
Intervention: MVA-compensable patients
Number of subjects: 391

Group type: COMPARATOR
Intervention: Non-compensable patients
Number of subjects: 391
Study: 18373127

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention (n = 46)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (n = 42)
Number of subjects: 88
Study: 15855334

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 30
Study: 12208438

Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg) + Thiopental (3 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental (5 mg/kg)
Number of subjects: 40
Study: 10350250

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 42
Study: 7536833

Group type: EXPERIMENTAL
Intervention: Nutrition intervention improving energy and nutrient intakes of women and preschool children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition intervention
Number of subjects: 0
Study: 1828191

Group type: EXPERIMENTAL
Intervention: Fluorodeoxyuridine (FUdR) at a dose of 0.3 mg/kg per day with oral leucovorin (LV) at a dose of 100 mg every hour for four doses before FUdR infusion and then every 4 hours during FUdR treatment.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorodeoxyuridine (FUdR) at a dose of 0.25 mg/kg per day with oral leucovorin (LV).
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorodeoxyuridine (FUdR) at a dose of 0.375 mg/kg per day with oral leucovorin (LV).
Number of subjects: 24
Study: 7469003

Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control (no promethazine)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Atosil (as a histamine blocker)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Overall reactions among females
Number of subjects: 450
Study: 31430369

Group type: EXPERIMENTAL
Intervention: BIC/FTC/TAF
Number of subjects: 570
Study: 29242062

Group type: COMPARATOR
Intervention: Intramuscular injections of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) at a dosage of 5 × 10^6 MSCs per injection, 30 injections total.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo injections (control group).
Number of subjects: 66
Study: 26746242

Group type: EXPERIMENTAL
Intervention: Risk factors for aggression (low maternal monitoring, depressed affect, anger reactivity)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Poor conflict management skills
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Acceptance of dating violence
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: None of the examined risk factors were unique to aggression type
Number of subjects: 399
Study: 24505303

Group type: EXPERIMENTAL
Intervention: Receiving an apology from player A to player B
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Forgiving judgments by player B
Number of subjects: 2
Study: 23399618

Group type: EXPERIMENTAL
Intervention: Advanced atherosclerotic lesions (Group B)
Number of subjects: 564

Group type: COMPARATOR
Intervention: No significant blood flow disorders (Group K)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Local thrombolysis
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Angioplastics and stenting after patency restoring
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Femoro-femoral bypass implantation
Number of subjects: 564
Study: 20395820

Group type: EXPERIMENTAL
Intervention: Intrathecal ketorolac (0.5-2.0 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intrathecal ketorolac (2.0 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intrathecal saline (control)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine
Number of subjects: 57
Study: 17567677

Group type: EXPERIMENTAL
Intervention: Prospective Public Health Intervention Studies Register
Number of subjects: 0
Study: 15811567

Group type: EXPERIMENTAL
Intervention: Educational intervention focusing on personal understanding of illness
Number of subjects: 104

Group type: COMPARATOR
Intervention: Care according to national guidelines for diabetes care
Number of subjects: 104
Study: 10759273

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone followed by misoprostol 400 µg
Number of subjects: 1589

Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone followed by misoprostol 400 µg
Number of subjects: 1589

Group type: COMPARATOR
Intervention: 200 mg mifepristone
Number of subjects: 1589
Study: 9031662

Group type: EXPERIMENTAL
Intervention: Nursing Assessment Decision Grid
Number of subjects: 282
Study: 8518766

Group type: EXPERIMENTAL
Intervention: Increased nurse support (n = 56)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (n = 47)
Number of subjects: 103
Study: 3103546

Group type: EXPERIMENTAL
Intervention: Fat emulsion administered at a constant rate over 24 hours, starting at 1 g/kg and increasing to a maximum of 4 g/kg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fat emulsion administered at a constant rate over 16 hours, starting at 1 g/kg and increasing to a maximum of 4 g/kg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fat emulsion administered at a constant rate of 4 g/kg a day over 24 hours
Number of subjects: 39
Study: 31594857

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 14,007 IU/d
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study: 28346912

Group type: EXPERIMENTAL
Intervention: EPO 300 (300 IU/kg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: EPO 1,000 (1,000 IU/kg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: EPO 3,000 (3,000 IU/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: VENT (no treatment)
Number of subjects: 23
Study: 26058417

Group type: EXPERIMENTAL
Intervention: 2 L/day of water for 30 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified, but implied to be those consuming less water)
Number of subjects: 34
Study: 23737079

Group type: EXPERIMENTAL
Intervention: CO2-laser treatment (9.6 µm, pulse-duration 20 µs, pulse-repetition-rate 20 Hz, average fluence 4.5 ± 0.5 J/cm², 20 laser pulses per spot)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoride varnish applications
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CO2-laser treatment
Number of subjects: 20
Study: 21482568

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil (600 mg iv every 12 h)
Number of subjects: 627

Group type: COMPARATOR
Intervention: Ceftriaxone (1 g iv every 24 h)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil and ceftriaxone
Number of subjects: 627
Study: 19923069

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (group M, n=23)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Spontaneous respiration (group S, n=20)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (group M)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Spontaneous respiration (group S)
Number of subjects: 53
Study: 17288832

Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Open discectomy
Number of subjects: 44
Study: 15154922

Group type: EXPERIMENTAL
Intervention: Two xylitol tablets two times a day (1.7 g xylitol d(‐1)) for 18 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Two xylitol tablets four times per day (3.4 g xylitol d(‐1)) for 18 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: No tablets (Control Group)
Number of subjects: 56
Study: 11249900

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 5477

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 5477
Study: 9442992

Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 26

Group type: COMPARATOR
Intervention: Additional therapy (Control)
Number of subjects: 26
Study: 7686799

Group type: EXPERIMENTAL
Intervention: Terfenadine (120 mg/day for 3 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2437521

Group type: EXPERIMENTAL
Intervention: Permethrin 1% creme rinse
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Lindane shampoo
Number of subjects: 1040
Study: 30169600

Group type: EXPERIMENTAL
Intervention: Metformin (3 g/day after a dose-escalation period over 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40
Study: 26835974

Group type: EXPERIMENTAL
Intervention: bivalent rLP2086 + HPV‐4
Number of subjects: 0

Group type: COMPARATOR
Intervention: bivalent rLP2086 + saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: saline + HPV‐4
Number of subjects: 0
Study: 26648210

Group type: EXPERIMENTAL
Intervention: Access to the 'Babies' Portal' social network
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no access to the social network)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Experimental group (access to the social network)
Number of subjects: 22
Study: 23332990

Group type: EXPERIMENTAL
Intervention: Frequent in-center hemodialysis (6-times-weekly)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Conventional in-center hemodialysis (3-times-weekly)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis (6-times-weekly)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Conventional nocturnal hemodialysis (3-times-weekly)
Number of subjects: 332
Study: 21551083

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no NAC treatment)
Number of subjects: 60
Study: 18469257

Group type: EXPERIMENTAL
Intervention: Low zinc diets (<11 mg/d) for 4-8 weeks
Number of subjects: 109

Group type: COMPARATOR
Intervention: High-phytate diets
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Low-zinc, low-phytate diets for several weeks
Number of subjects: 109
Study: 17288763

Group type: EXPERIMENTAL
Intervention: Early invasive strategy
Number of subjects: 545

Group type: COMPARATOR
Intervention: Early conservative strategy
Number of subjects: 545
Study: 12965069

Group type: EXPERIMENTAL
Intervention: 10F pigtail catheter
Number of subjects: 30

Group type: COMPARATOR
Intervention: 22F Councill‐tip catheter
Number of subjects: 30
Study: 11128851

Group type: EXPERIMENTAL
Intervention: Exhaustive cycling at 65% VO2peak
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exhaustive cycling at 75% VO2peak
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exhaustive cycling at 85% VO2peak
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exhaustive cycling at 95% VO2peak
Number of subjects: 10
Study: 8136334

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1